Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands
· Delayed Price · Currency is EUR 1.300
+0.010 (0.78%)
Apr 29, 2026, 5:35 PM CET
Vivoryon Therapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.62 | 9.37 | 18.56 | 26.56 | 14.66 | Upgrade
|
| Short-Term Investments | 0.03 | 0.02 | 10.02 | 0.01 | - | Upgrade
|
| Cash & Short-Term Investments | 5.65 | 9.39 | 28.58 | 26.56 | 14.66 | Upgrade
|
| Cash Growth | -39.78% | -67.16% | 7.61% | 81.17% | -44.27% | Upgrade
|
| Other Receivables | - | 0.31 | 1.01 | 3.97 | 3.36 | Upgrade
|
| Receivables | - | 0.31 | 1.01 | 3.97 | 3.36 | Upgrade
|
| Prepaid Expenses | - | 0.37 | 0.22 | 0.17 | 0.18 | Upgrade
|
| Other Current Assets | 0.78 | - | - | - | 2.03 | Upgrade
|
| Total Current Assets | 6.43 | 10.07 | 29.81 | 30.69 | 20.23 | Upgrade
|
| Property, Plant & Equipment | 0.12 | 0.12 | 0.08 | 0.18 | 0.29 | Upgrade
|
| Other Intangible Assets | 0.8 | 0.87 | 0.94 | 0.49 | 0.53 | Upgrade
|
| Other Long-Term Assets | 0.17 | 0.23 | - | 0.01 | 3.47 | Upgrade
|
| Total Assets | 7.52 | 11.28 | 30.83 | 31.38 | 24.52 | Upgrade
|
| Accounts Payable | 0.46 | 1.02 | 2.89 | 2.54 | 4.36 | Upgrade
|
| Accrued Expenses | - | 0.31 | 0.24 | 0.25 | 0.23 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.06 | 0.04 | 0.09 | 0.09 | Upgrade
|
| Other Current Liabilities | 0.32 | 0.01 | 0.01 | 0.38 | 0.37 | Upgrade
|
| Total Current Liabilities | 0.84 | 1.4 | 3.18 | 3.27 | 5.05 | Upgrade
|
| Long-Term Leases | 0.04 | 0.04 | - | 0.04 | 0.13 | Upgrade
|
| Pension & Post-Retirement Benefits | 1.23 | 1.32 | 1.35 | 1.32 | 1.82 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.23 | 0.43 | Upgrade
|
| Other Long-Term Liabilities | 0.68 | 0.65 | 0.01 | 0.01 | 0.53 | Upgrade
|
| Total Liabilities | 2.79 | 3.4 | 4.55 | 4.87 | 7.96 | Upgrade
|
| Common Stock | 0.3 | 0.26 | 26.07 | 24.11 | 20.05 | Upgrade
|
| Additional Paid-In Capital | 166.22 | 161.48 | 135.67 | 113.38 | 83.21 | Upgrade
|
| Retained Earnings | -178.22 | -169.37 | -148.8 | -120.46 | -92.3 | Upgrade
|
| Comprehensive Income & Other | 16.43 | 15.51 | 13.34 | 9.48 | 5.6 | Upgrade
|
| Shareholders' Equity | 4.73 | 7.88 | 26.28 | 26.51 | 16.56 | Upgrade
|
| Total Liabilities & Equity | 7.52 | 11.28 | 30.83 | 31.38 | 24.52 | Upgrade
|
| Total Debt | 0.11 | 0.1 | 0.04 | 0.13 | 0.22 | Upgrade
|
| Net Cash (Debt) | 5.54 | 9.28 | 28.55 | 26.43 | 14.44 | Upgrade
|
| Net Cash Growth | -40.28% | -67.48% | 8.00% | 83.07% | -44.46% | Upgrade
|
| Net Cash Per Share | 0.21 | 0.36 | 1.13 | 1.20 | 0.72 | Upgrade
|
| Filing Date Shares Outstanding | 27.52 | 26.07 | 26.07 | 24.11 | 20.05 | Upgrade
|
| Total Common Shares Outstanding | 27.52 | 26.07 | 26.07 | 24.11 | 20.05 | Upgrade
|
| Working Capital | 5.59 | 8.67 | 26.63 | 27.43 | 15.18 | Upgrade
|
| Book Value Per Share | 0.17 | 0.30 | 1.01 | 1.10 | 0.83 | Upgrade
|
| Tangible Book Value | 3.93 | 7.02 | 25.34 | 26.01 | 16.02 | Upgrade
|
| Tangible Book Value Per Share | 0.14 | 0.27 | 0.97 | 1.08 | 0.80 | Upgrade
|
| Machinery | - | 0.13 | 0.13 | 0.12 | 0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.